BDBM323125 2,5-difluoro-4-((trans-6-oxo-4-(2,4,5-trifluorophenyl)piperidin-3-yl)methoxy)-N-(1,2,4-thiadiazol-5-yl(benzenesulfonamide::US9630929, Example 101

SMILES Fc1cc(F)c(cc1F)C1CC(=O)NC[C@H]1COc1cc(F)c(cc1F)S(=O)(=O)Nc1ncns1

InChI Key InChIKey=MNLMEZHEVLCYTN-RGURZIINSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 323125   

TargetSodium channel protein type 9 subunit alpha(Homo sapiens (Human))
Xenon Pharmaceuticals

US Patent
LigandPNGBDBM323125(2,5-difluoro-4-((trans-6-oxo-4-(2,4,5-trifluorophe...)
Affinity DataIC50:  4.49E+3nMAssay Description:The following patch voltage clamp electrophysiology studies were performed on representative compounds of the invention using human embryonic kidney ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent